CrossrefInfokarte
Influence of Alternative Tubulin Inhibitors on the Potency of Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate
Cancer and Clinical Oncology · 2012
DOI: 10.5539/cco.v1n2p49 ↗Abstract
Kein Abstract verfügbar.
EUVIMED